← Back to directory

David O. Bates

Researcher Next ID · RN-043111

Researcher · Biochemistry, Genetics and Molecular Biology

Political Research Associates

Somerville, South Africa

Accepting doctoral researchersFunding unknown
Works count
542
Citation count
22,918
H-index
81
i10-index
234

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Angiogenesis and VEGF in Cancer
Lymphatic System and Diseases
Retinal Diseases and Treatments
Cell Adhesion Molecules Research
Multiple Sclerosis Research Studies

Publications

  • Cervical cancer in low and middle‑income countries (Review)

    Oncology Letters · 2020 · https://doi.org/10.3892/ol.2020.11754

  • Consensus guidelines for the use and interpretation of angiogenesis assays

    Angiogenesis · 2018 · https://doi.org/10.1007/s10456-018-9613-x

  • Hallmarks of alternative splicing in cancer

    Oncogene · 2013 · https://doi.org/10.1038/onc.2013.533

  • Development and initial application of a fully integrated photoacoustic micro-ultrasound system

    IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · 2013 · 10.1109/tuffc.2013.2646

  • Loss of the Endothelial Glycocalyx Links Albuminuria and Vascular Dysfunction

    Journal of the American Society of Nephrology · 2012 · 10.1681/asn.2012010017

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    The Lancet Neurology · 2011 · 10.1016/s1474-4422(11)70149-1

  • Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels

    Circulation · 2011 · 10.1161/circulationaha.110.948570

  • WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing

    Cancer Cell · 2011 · 10.1016/j.ccr.2011.10.016

  • Vascular endothelial growth factors and vascular permeability

    Cardiovascular Research · 2010 · https://doi.org/10.1093/cvr/cvq105

  • Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms

    Journal of Biological Chemistry · 2009 · 10.1074/jbc.m109.074930

  • Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

    The Lancet Neurology · 2009 · 10.1016/s1474-4422(09)70021-3

  • VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

    British Journal of Cancer · 2008 · 10.1038/sj.bjc.6604308

  • VEGF-A splicing: the key to anti-angiogenic therapeutics?

    Nature reviews. Cancer · 2008 · 10.1038/nrc2505

  • Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

    Journal of Cell Science · 2008 · 10.1242/jcs.016410

  • Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

    The Lancet Neurology · 2007 · 10.1016/s1474-4422(07)70078-9

  • Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor

    Diabetologia · 2005 · 10.1007/s00125-005-1951-8

  • VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant

    Cancer Research · 2004 · 10.1158/0008-5472.can-04-0934

  • Regulation of vascular permeability by vascular endothelial growth factors

    Vascular Pharmacology · 2002 · 10.1016/s1537-1891(03)00011-9

  • Regulation of microvascular permeability by vascular endothelial growth factors*

    Journal of Anatomy · 2002 · 10.1046/j.1469-7580.2002.00066.x

  • Preventable Medical Injuries in Older Patients

    Archives of Internal Medicine · 2000 · 10.1001/archinte.160.18.2717

  • Incidence and preventability of adverse drug events in nursing homes

    The American Journal of Medicine · 2000 · https://doi.org/10.1016/s0002-9343(00)00451-4

  • New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests

    The Lancet · 1997 · 10.1016/s0140-6736(97)07472-2

  • Autoantibodies to a 128-kd Synaptic Protein in Three Women with the Stiff-Man Syndrome and Breast Cancer

    New England Journal of Medicine · 1993 · 10.1056/nejm199302253280805

  • Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery.

    Stroke · 1987 · 10.1161/01.str.18.4.700

  • Early neurological complications of coronary artery bypass surgery.

    BMJ · 1985 · 10.1136/bmj.291.6506.1384

Current projects

    No projects listed.